terazosin has been researched along with buflomedil in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Arrostuto, A; Correo, S; Ingurgio, NC; Licata, G; Martino, S; Paterna, S | 1 |
1 trial(s) available for terazosin and buflomedil
| Article | Year |
|---|---|
[The effects of terazosin hydrochloride and buflomedil in patients with hemicrania without aura].
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Chronic Disease; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Migraine Disorders; Prazosin; Pyrrolidines; Surveys and Questionnaires; Time Factors; Vasodilator Agents | 1994 |
3 other study(ies) available for terazosin and buflomedil
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |